skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: Database: SpringerOpen remove resource type: Conference Proceedings remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Deep learning-based evaluation of normal bone marrow activity in 18F-NaF PET/CT in patients with prostate cancer
Deep learning-based evaluation of normal bone marrow activity in 18F-NaF PET/CT in patients with prostate cancer
Material Type:
Conference Proceeding 		Add to My Research

Deep learning-based evaluation of normal bone marrow activity in 18F-NaF PET/CT in patients with prostate cancer

European Congress of Radiology (ECR),Vienna, Austria,2020-07-15 - 2020-07-19, 2020, Vol.11 (Suppl. 1), p.349 [Peer Reviewed Journal]

ISSN: 1869-4101 ;EISSN: 1869-4101 ;DOI: 10.1186/s13244-020-00851-0

Full text available

Citations Cited by
2
666 Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
666 Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
Material Type:
Conference Proceeding 		Add to My Research

666 Phase 2, single arm study of CG0070 combined with pembrolizumab in patients with non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A696-A696 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0666

Full text available

Citations Cited by
3
789 Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144–01 study)
789 Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144–01 study)
Material Type:
Conference Proceeding 		Add to My Research

789 Lifileucel TIL cell monotherapy in patients with advanced melanoma after progression on immune checkpoint inhibitors (ICI) and targeted therapy: pooled analysis of consecutive cohorts (C-144–01 study)

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A821-A822 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.0789

Full text available

Citations Cited by
4
1410 Essential role of innate effector immune responses for the therapeutic efficacy of peptide vaccine to treat HPV+ tumors
1410 Essential role of innate effector immune responses for the therapeutic efficacy of peptide vaccine to treat HPV+ tumors
Material Type:
Conference Proceeding 		Add to My Research

1410 Essential role of innate effector immune responses for the therapeutic efficacy of peptide vaccine to treat HPV+ tumors

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1466-A1466 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1410

Full text available

Citations Cited by
5
1250 A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy drugs
1250 A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy drugs
Material Type:
Conference Proceeding 		Add to My Research

1250 A novel in vivo PBMC humanized mouse platform for long-term analysis of efficacy and toxicity of T cell-based immunotherapy drugs

Journal for immunotherapy of cancer, 2022, Vol.10 (Suppl 2), p.A1298-A1298 [Peer Reviewed Journal]

2022 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2022-SITC2022.1250

Full text available

Citations Cited by
6
P04.04 Programmed death-ligand 1 positron emission tomography imaging during neoadjuvant (chemo)radiotherapy in esophageal and rectal cancer (PETNEC): a prospective non-randomized open-label single-center pilot study
P04.04 Programmed death-ligand 1 positron emission tomography imaging during neoadjuvant (chemo)radiotherapy in esophageal and rectal cancer (PETNEC): a prospective non-randomized open-label single-center pilot study
Material Type:
Conference Proceeding 		Add to My Research

P04.04 Programmed death-ligand 1 positron emission tomography imaging during neoadjuvant (chemo)radiotherapy in esophageal and rectal cancer (PETNEC): a prospective non-randomized open-label single-center pilot study

Journal for immunotherapy of cancer, 2021, Vol.9 (Suppl 1), p.A17-A18 [Peer Reviewed Journal]

2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2021-ITOC8.33

Full text available

Citations Cited by
7
P02.03 Automated cell type specific PD-L1 quantification by artificial intelligence using high throughput bleach & stain 15-marker multiplex fluorescence immunohistochemistry in human cancers
P02.03 Automated cell type specific PD-L1 quantification by artificial intelligence using high throughput bleach & stain 15-marker multiplex fluorescence immunohistochemistry in human cancers
Material Type:
Conference Proceeding 		Add to My Research

P02.03 Automated cell type specific PD-L1 quantification by artificial intelligence using high throughput bleach & stain 15-marker multiplex fluorescence immunohistochemistry in human cancers

Journal for immunotherapy of cancer, 2021, Vol.9 (Suppl 1), p.A8-A9 [Peer Reviewed Journal]

2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2051-1426 ;DOI: 10.1136/jitc-2021-ITOC8.15

Full text available

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait